Literature DB >> 29602393

Mitochondrial Dysfunction and Signaling in Diabetic Kidney Disease: Oxidative Stress and Beyond.

Nicole Bernadette Flemming1, Linda Alba Gallo1, Josephine Maree Forbes2.   

Abstract

The kidneys are highly metabolic organs that produce vast quantities of adenosine triphosphate via oxidative phosphorylation and, as such, contain many mitochondria. Although mitochondrial reactive oxygen species are involved in many physiological processes in the kidneys, there is a plethora of evidence to suggest that excessive production may be a pathologic mediator of many chronic kidney diseases, including diabetic kidney disease. Despite this, results from clinical testing of antioxidant therapies have been generally underwhelming. However, given the many roles of mitochondria in cellular functioning, pathways other than reactive oxygen species production may prevail as pathologic mediators in diabetic kidney disease. Accordingly, in this review, mitochondrial dysfunction in a broader context is discussed, specifically focusing on mitochondrial respiration and oxygen consumption, intrarenal hypoxia, oxidative stress, mitochondrial uncoupling, and networking.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mitochondrial dysfunction; diabetic kidney disease; hypoxia; oxidative stress; uncoupling

Mesh:

Year:  2018        PMID: 29602393     DOI: 10.1016/j.semnephrol.2018.01.001

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  13 in total

Review 1.  Mechanisms of Synergistic Interactions of Diabetes and Hypertension in Chronic Kidney Disease: Role of Mitochondrial Dysfunction and ER Stress.

Authors:  Zhen Wang; Jussara M do Carmo; Alexandre A da Silva; Yiling Fu; John E Hall
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

2.  Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice.

Authors:  Daniel L Galvan; Jianyin Long; Nathanael Green; Benny H Chang; Jamie S Lin; Paul Schumacker; Luan D Truong; Paul Overbeek; Farhad R Danesh
Journal:  J Clin Invest       Date:  2019-05-07       Impact factor: 14.808

3.  Development of a point-of-contact technique to measure adenosine triphosphate: A quality improvement study.

Authors:  Janet Pierce; John B Hiebert; Diane Mahoney; Qiuhua Shen; Jill Peltzer; Faith Rahman; Samantha Johnson; John T Pierce
Journal:  Ann Med Surg (Lond)       Date:  2019-04-05

Review 4.  Eat Your Broccoli: Oxidative Stress, NRF2, and Sulforaphane in Chronic Kidney Disease.

Authors:  Scott E Liebman; Thu H Le
Journal:  Nutrients       Date:  2021-01-18       Impact factor: 5.717

5.  Streptozotocin induces alpha-2u globulin nephropathy in male rats during diabetic kidney disease.

Authors:  Kanchana Kengkoom; Wannee Angkhasirisap; Tapanee Kanjanapruthipong; Rongdej Tungtrakanpoung; Khwanchanok Tuentam; Naphatson Phansom; Sumate Ampawong
Journal:  BMC Vet Res       Date:  2021-03-04       Impact factor: 2.741

6.  MicroRNA-499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes-associated end-stage renal disease.

Authors:  Manal S Fawzy; Essam Al Ageeli; Saeed Awad Al-Qahtani; Baraah T Abu Alsel; Shahad W Kattan; Walla Alelwani; Eman A Toraih
Journal:  Exp Ther Med       Date:  2021-11-22       Impact factor: 2.447

7.  Effects and Mechanism of Ganoderma lucidum Polysaccharides in the Treatment of Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats.

Authors:  Yu Hu; Shu-Xiang Wang; Fu-Yu Wu; Ke-Jia Wu; Rui-Ping Shi; Li-Hong Qin; Chun-Feng Lu; Shu-Qiu Wang; Fang-Fang Wang; Shaobo Zhou
Journal:  Biomed Res Int       Date:  2022-03-08       Impact factor: 3.411

Review 8.  Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review.

Authors:  Nicole Flemming; Laura Pernoud; Josephine Forbes; Linda Gallo
Journal:  Cells       Date:  2022-08-10       Impact factor: 7.666

9.  PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury.

Authors:  Ying Wang; Chengyuan Tang; Juan Cai; Guochun Chen; Dongshan Zhang; Zhuohua Zhang; Zheng Dong
Journal:  Cell Death Dis       Date:  2018-11-01       Impact factor: 8.469

Review 10.  Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.

Authors:  Pei-Hui Lin; Pu Duann
Journal:  Front Physiol       Date:  2020-09-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.